Correlation between using daily aspirin and preventing cancer

Introduction

Humans suffer from more than 100 types of cancer. Cancers first emerge inside a human cell. When the body is functioning properly, it occasionally needs to produce more cells. It does so by allowing old cells to die and younger cells to divide and form new cells. When cancer emerges, the cell regulatory mechanism goes awry and cells continue to divide incessantly, ultimately leading to a tumescent mass. A difficulty in preventing and diagnosing cancers is that it may take many years for a tumor to grow sufficiently for detection. This paper gives a correlation between using aspirin daily and cancer prevention.

Discussion

The annual rate of newly reported cancer cases increased during the 1970s and 1980s yet has been slowly decreasing since the mid-1990s. However, this general pattern conceals diverse trends among diverse types of cancers: cancers of the digestive system, from the mouth and throat to the stomach and colon, have decreased, while lung (particularly for women), bladder, prostate, kidney, liver, brain, lymphomas, and melanomas have increased (Doll, Pp. 3-21).

Many common oral narcotics are a combination of medications. Narcotics are prepared with other analgesics such as acetaminophen (brand name when used alone: Aspirin (acetylsalicylic acid, or ASA), Tylenol, commonly abbreviated as APAP), or ibuprofen (common brand names when used alone: Motrin, Advil). These medications are designed to give effective pain relief, with a slow release of narcotics over a 12-hour period. It is very helpful in conditions of chronic severe pain, such as certain kinds of cancer (Cuzick, Pp. 501-507). After analyzing data drawn from over 25,000 human subjects, a team of researchers at Oxford University has conclusively demonstrated that long-term, low-dose aspirin therapy (75 mg per day) effectively combats multiple forms of cancer—and prevents cancer death (Rothwell, et.al, Pp. 31-41).

Separate observational studies have ...